Corbus Pharmaceuticals Holdings Inc. Stock Falls 7.0%, Underperforms Peers
Dow Jones2026/08/10 20:32This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. slid 7.0% to $9.46 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,605.36 and Dow Jones Industrial Average falling 0.1% to 53,975.98.
The stock's fall snapped a four-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 54.0% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 0.4% to $5.02, Fortress Biotech Inc. rose 3.0% to $2.75, and Viking Therapeutics Inc. rose 0.53% to $34.44.
Trading volume totaled 335,566, compared to the 50-day average of 412,692.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 10, 2026 16:32 ET (20:32 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic (ANT.US) targets IPO at trillion-dollar valuation; venture capitalists warn it may signal the peak of the AI market
Venture capitalist Selby warns that Anthropic’s trillion-dollar valuation IPO could signal the peak of the AI market, and the expiration of the lock-up period may trigger a chain reaction of corrections.
Wall Street's "Great Rotation" Underway: AI Trading Fades, Tech Stocks Out of Favor, Capital Flows Shift to Defensive Sectors
Analysts point out that as investors shift their bets from high-risk technology sectors to defensive stocks, the market is currently in a "state of alert".

Barrick Gold (ABGC.US) applies for U.S. IPO, aiming to raise up to 6 billion dollars
American Barrick Gold has submitted its initial public offering (IPO) application to the U.S. Securities and Exchange Commission (SEC).
